CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 2,591 enrolled
Drug / intervention
Culturally Tailored Anti-Smoking Messagesother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05499520
NCT05499520N/ACompleted
CompareCT.gov

Project RESIST: Evaluating the Effects of Anti-smoking Inoculation Messages Among Young Adult Sexual Minority Women

Abramson Cancer Center at Penn Medicine·interventional·Posted Aug 12, 2022·Updated Jul 31, 2024

In Brief

A clinical study evaluating Culturally Tailored Anti-Smoking Messages for Cigarette Smoking Behavior. Completed, enrolled 2,591 participants across 1 site.

Detailed Summary

Project RESIST is an R01 study funded by NCI focused on determining the effects of using culturally tailored inoculation approaches to increase resilience to tobacco marketing influences among young adult sexual minority women ages 18-30 and incorporates critical stakeholder inputs that support later adoption and implementation. The study team is utilizing formative research to design and pre-test anti-smoking messages and two national longitudinal online survey experiments.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCigarette Smoking Behavior
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI), Harvard School of Public Health (HSPH), Stanford University, Dana-Farber Cancer Institute, Fenway Community Health

Timeline

N/ACompletedFinished
2023202420252026
First PostedAug 12, 2022
Enrollment StartSep 21, 2022
Primary CompletionJul 5, 2023
Study CompletionAug 15, 2023
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 3.9 years ago

Interventions

Culturally Tailored Anti-Smoking Messagesother

Anti-smoking messages will be administered online via a Qualtrics survey.